So far, vascular endothelial growth factor (VEGF) appears to be the main driver for the progression of non proliferative-DR to proliferative-DR (PDR) characterized by ischemia leading to aberrant neovascularization, blood vessel leakage and macular edema (DME) [3–5]. The gene discussed is VEGFA; the disease is ischemia.